Ipsen

Ipsen is active in the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a profitable year for Ipsen investors

Over the period from December 2015 till December 2016 the stock gained around 15 percent. Over the past 5 years the stock rose a massive 171,55 percent. Ipsen's revenues between 2011 and 2015 were quite similar and moved between 1,28 billion euros and 1,52 billion euros. The net results between 2011 and 2015 were far from constant and fluctuated between 54,71 million euros and 187,7 million euros.

The French company paid out dividends in the past 5 years. Ipsen's dividend return over the period 2011 - 2015 was around 4,1 percent per year.

Ipsen' balance mostly financed with equity

At the end of 2015 the French company's balance sheet was worth 1,94 billion euros. 715,5 million euros (36,92 percent of the total balance sheet) was financed by debt.

At the end of 2015 the French company had around 82,13 million stocks listed on the stock exchange(s).

On this page you can find all Ipsen's financial reports. More information about Ipsen can be found it's website. .